Increased Response Rates to Salvage Chemotherapy Administered after PD-1/PD-L1 Inhibitors in Patients with Non-Small Cell Lung Cancer
Journal of Thoracic Oncology (2017), doi: 10.1016/j.jtho.2017.10.011.
Impact of Nivolumab Versus Docetaxel on Health-Related Quality of Life and Symptoms in Patients With Advanced Squamous Non-Small Cell Lung Cancer: Results From the CheckMate 017 Study
Journal of Thoracic Oncology (2017), doi: 10.1016/j.jtho.2017.10.029.
Randomized Phase III Trial of Low Molecular Weight Heparin Enoxaparin in Addition to Standard Treatment in Small Cell Lung Cancer: the RASTEN Trial
Annals of Oncology, mdx716, https://doi.org/10.1093/annonc/mdx716 Published: 02 November 2017
Letter to the editor
Nivolumab in non-small cell lung cancer with EGFR mutation Annals of Oncology, mdx745, https://doi.org/10.1093/annonc/mdx745 Published: 17 November 2017
The European Society for Medical Oncology (ESMO) Precision Medicine Glossary
Annals of Oncology, mdx707, https://doi.org/10.1093/annonc/mdx707 Published: 13 November 2017